Skip to main content

American Chemical Society Pledges 2.5 Million Dollars to Help Students Graduate

Severe cuts to science research funding put graduate students at risk of not finishing their degrees. The American Chemical Society launched a grant to support students in crisis. 

Written byAndrea Lius, PhD
| 2 min read
A paper protest sign reads “Save Our Scientists”, signifying the crisis that US scientists are facing due to severe federal research funding cuts.
Register for free to listen to this article
Listen with Speechify
0:00
2:00

Severe research funding cuts have left scientists in the United States and their trainees in the lurch. The American Chemical Society (ACS) refuses to stand back.

The organization recently launched the ACS Graduate Student Success Grant initiative, offering their support to 100 students pursuing a master’s or PhD in chemistry who are within a year of degree completion but are at risk of not finishing due to sudden termination of their advisors’ funding. The application will run from September 15 to October 1 this year, and successful candidates will be notified by October 15. The program will grant $25,000 to each student, and ACS plans to disburse the awards in 2025.

“That’s 2.5 million dollars to support students at the time when they need it the most,” said Wayne Jones, chair of the ACS board of directors, during his opening address at the Fall 2025 ACS meeting. “[This program] helps ensure the continuity of training and protects the future of our US-based scientific workforce.”

Elizabeth Komives, a chemist at the University of California, San Diego, said, “I wasn't aware that ACS is doing this, but it is sorely needed. I am currently scrambling to find funding for several graduate students in our program.”

Even chemists who haven’t been directly impacted by the federal funding cuts commended the initiative. “I have not had a grant terminated but I worry about it a lot—that is so awesome for ACS to step up like this,” said Vicki Grassian, a physical chemist at the University of California, San Diego.

Jonathan Barnes, a chemist at Washington University in St. Louis, added, “[This initiative] is an excellent demonstration of how to lead by example.”

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Image of Andrea Lius.

    Andrea Lius is an intern at The Scientist. She earned her PhD in pharmacology from the University of Washington. Besides science, she also enjoys writing short-form creative nonfiction.

    View Full Profile

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
The Scientist Digest cover September 2026
September 2026

Multiplex Microscopy Becomes Easier with Encoded Antibodies

A new system that enables researchers to uniquely tag monoclonal antibodies for use in microscopy could help simplify complex imaging studies.

View this Issue
Essential Genes Are Dominantly Activated by Single Transcription Factors

Essential Genes Are Dominantly Activated by Single Transcription Factors

EpiCypher Logo
Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Rethinking ALS Biomarkers: From Discovery to Clinical Impact

Alamar Biosciences logo
Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Engineering CAR-Neutrophils In Vivo to Target Glioblastoma

Miltenyi
Best Practices for qPCR Assay Design and Optimization

Best Practices for qPCR Assay Design and Optimization

Bio-Rad

Products

Closeup image of a multi channel pipette dispensing pink liquid into a 96-well plate.

The ASSIST PLUS pipetting robot for affordable workflow automation

Integra Logo
Single cells in suspension

Rapidly isolate primary cells and make uniform single-cell suspensions with Corning® Cell Strainers

Corning logo
Abstract image representing cell membranes linked together.

CellBrite® Steady Membrane Stain: Cell surface staining built for real-time imaging

Biotium
sino biological logo

Monod Bio Licenses AI-designed Protein Technologies to SignalChem Biotech for Custom Discovery Assays